Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02373878 · ClinicalTrials.gov registry record · NA
Telecoaching Plus a Portion Control Device for Weight Management in the Primary Care Setting
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02373878: Completed NA study, sponsored by Mayo Clinic.
NCT02373878 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02373878, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
The purpose of this study was to evaluate the impact of telecoaching conducted by a counselor trained in motivational interviewing paired with a portion control device for obese patients receiving care in a certified patient-centered medical home. The investigators will conduct a randomized, controlled clinical trial evaluating the effectiveness of a telecoaching intervention with a portion control device.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Telecoaching plus Plate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-06 |
| Phase | NA |
What the finished NCT02373878 record still lists
NCT02373878 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02373878 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02373878 about?
NCT02373878 is a clinical study titled "Telecoaching Plus a Portion Control Device for Weight Management in the Primary Care Setting". The purpose of this study was to evaluate the impact of telecoaching conducted by a counselor trained in motivational interviewing paired with a portion control device for obese patients receiving care in a certified patient-centered medical home. The investigators will conduct a randomized, control...
What is the current status of trial NCT02373878?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2011-05. Estimated completion is 2012-06.
What interventions are being tested in trial NCT02373878?
The interventions under investigation include: Usual Care (BEHAVIORAL), Telecoaching plus Plate (BEHAVIORAL).
Who is sponsoring clinical trial NCT02373878?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02373878's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia